SCHEMBL2810265

SCHEMBL2810265

CC(=CSc1ccc(C)cc1)C(=O)Nc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 1/20 0.47
HSD17B10 Q99714 1/20 0.47
KMT2A Q03164 5/20 0.47
MEN1 O00255 4/20 0.47
ALDH1A1 P00352 4/20 0.47
TDP1 Q9NUW8 2/20 0.46
MAPT P10636 5/20 0.46
LMNA P02545 3/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
NPC1 O15118 8/20 0.44
RAB9A P51151 8/20 0.44
SMN1; SMN2 Q16637 5/20 0.44
TAAR1 Q96RJ0 1/20 0.42
POLB P06746 1/20 0.42
HPGD P15428 2/20 0.42
TP53 P04637 1/20 0.42
EGFR P00533 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2810262 1.00 NAPRT (0.47) NAPRTHSD17B10KMT2AMEN1ALDH1A1
SCHEMBL2812062 0.94 ALDH1A1 (0.50) NAPRTHSD17B10KMT2AMEN1ALDH1A1
SCHEMBL2812064 0.94 ALDH1A1 (0.50) NAPRTHSD17B10KMT2AMEN1ALDH1A1
SCHEMBL2809764 0.92 TDP1 (0.55) KMT2AMEN1ALDH1A1TDP1MAPT
SCHEMBL2809761 0.92 TDP1 (0.55) KMT2AMEN1ALDH1A1TDP1MAPT
SCHEMBL2812834 0.91 HSD17B10 (0.53) NAPRTHSD17B10KMT2AMEN1ALDH1A1
SCHEMBL2812831 0.91 HSD17B10 (0.53) NAPRTHSD17B10KMT2AMEN1ALDH1A1
SCHEMBL2807273 0.87 RAB9A (0.47) NAPRTHSD17B10KMT2AMEN1ALDH1A1
SCHEMBL2809174 0.87 RAB9A (0.47) NAPRTHSD17B10KMT2AMEN1ALDH1A1
SCHEMBL2807280 0.87 RAB9A (0.47) NAPRTHSD17B10KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 NAPRT 3883/4885HSD17B10 1243/4885KMT2A 3324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.